Cases
Cases 1 - 10 of 13
RSS Feed | View as table | Sort by last update
Exelixis, Inc. v. Teva Pharmaceutical Industries Limited et al
as 1:2022cv01168
Plaintiff: Exelixis, Inc.
Defendant: Teva Pharmaceutical Industries Limited, Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals Development, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Teva Pharmaceuticals, Inc. et al
as 1:2022cv00965
Plaintiff: Neurocrine Biosciences, Inc.
Defendant: Teva Pharmaceuticals, Inc., Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Teva Pharmaceuticals, Inc. et al
as 1:2022cv00092
Plaintiff: Neurocrine Biosciences, Inc.
Defendant: Teva Pharmaceuticals, Inc., Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc. and others
Cause Of Action: 35 U.S.C. § 271
Novo Nordisk Inc. et al v. Teva Pharmaceuticals, Inc. et al
as 1:2021cv01782
Defendant: Teva Pharmaceuticals, Inc., Teva Pharmaceuticals Development, Inc. and Teva Pharmaceuticals USA, Inc.
Plaintiff: Novo Nordisk Inc. and Novo Nordisk A/S
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, Inc. et al v. Teva Pharmaceuticals Development, Inc. et al
as 1:2021cv01353
Plaintiff: Anacor Pharmaceuticals, Inc. and PF PRISM IMB B.V.
Defendant: Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, LLC, et al., v. Dr. Reddys Laboratories, Ltd., et al.,
as 1:2021cv01348
Plaintiff: Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V. and Anacor Pharmaceuticals, LLC
Defendant: Alkem Laboratories Ltd., Dr. Reddys Laboratories, Ltd., Dr. Reddy's Laboratories, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BIOMARIN PHARMACEUTICAL INC. et al v. TEVA PHARMACEUTICALS, INC. f/k/a TEVA PHARMACEUTICALS DEVELOPMENT, INC.
as 2:2021cv15392
Plaintiff: BIOMARIN PHARMACEUTICAL INC. and MERCK & CIE
Defendant: TEVA PHARMACEUTICALS, INC. f/k/a TEVA PHARMACEUTICALS DEVELOPMENT, INC.
Cause Of Action: 35 U.S.C. § 271
Neurocrine Biosciences, Inc. v. Teva Pharmaceuticals, Inc. et al
as 1:2021cv01148
Plaintiff: Neurocrine Biosciences, Inc.
Defendant: Teva Pharmaceuticals, Inc., Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc. and others
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Lotus Pharmaceutical Co., Ltd. et al
as 1:2021cv01107
Plaintiff: Novartis Pharmaceuticals Corporation and Dana-Farber Cancer Institute, Inc.
Defendant: Lotus Pharmaceutical Co., Ltd. and Teva Pharmaceuticals Development, Inc.
Cause Of Action: 35 U.S.C. § 1
Neurocrine Biosciences, Inc. v. Teva Pharmaceuticals, Inc. et al
as 1:2021cv01043
Plaintiff: Neurocrine Biosciences, Inc.
Defendant: Teva Pharmaceuticals, Inc., Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc. and others
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?